Literature DB >> 14244103

DOUBLE ANEUPLOIDY: TRISOMY 21 AND XO--XX SEX CHROMOSOME MOSAICISM.

A W ROOT, A M BONGIOVANNI, S BREIBART, W J MELLMAN.   

Abstract

Keywords:  BLOOD GROUPS; CHROMOSOME ABNORMALITIES; CYTOLOGY; DERMATOGLYPHICS; INFANT, NEWBORN; MOSAICISM; SEX CHROMATIN; TRISOMY

Mesh：

Substances：

Year:  1964        PMID： 14244103     DOI： 10.1016/s0022-3476(64)80020-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Double aneuploidy (47,XX,21+-45,X) arising through simultaneous double non-disjunction.

Authors:  M M Cohen; R G Davidson
Journal:  J Med Genet       Date:  1972-06       Impact factor: 6.318

Review 2.  Down's syndrome. Current stage of cytogenetic research.

Authors:  M Mikkelsen
Journal:  Humangenetik       Date:  1971

3.  X chromosome long arm deletion in a patient with Down's syndrome.

Authors:  F W Luthardt; C G Palmer
Journal:  J Med Genet       Date:  1971-09       Impact factor: 6.318

4.  Congenital dislocation of the knees in a child with Down-mosaic Turner syndrome.

Authors:  A R Gatrad
Journal:  J Med Genet       Date:  1981-04       Impact factor: 6.318

5.  Trisomy D1 (13-15) associated with XO-XY mosaicism.

Authors:  N E France; P G Evison; L J Butler; G J Snodgrass; L Crome; C G Keith
Journal:  J Med Genet       Date:  1967-06       Impact factor: 6.318

6.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

Review 7.  Down-Turner syndrome: case report and review.

Authors:  G J Van Buggenhout; B C Hamel; J C Trommelen; H Mieloo; D F Smeets
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.